Cleared Abbreviated

K092993 - ADVIA CENTAUR CYCLOSPORINE MASTER CURVE MATERIAL (FDA 510(k) Clearance)

Nov 2009
Decision
53d
Days
Class 1
Risk

K092993 is an FDA 510(k) clearance for the ADVIA CENTAUR CYCLOSPORINE MASTER CURVE MATERIAL. This device is classified as a Single (specified) Analyte Controls (assayed And Unassayed) (Class I - General Controls, product code JJX).

Submitted by Siemens Healthcare Diagnostics (Tarrytown, US). The FDA issued a Cleared decision on November 20, 2009, 53 days after receiving the submission on September 28, 2009.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1660.

Submission Details

510(k) Number K092993 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 28, 2009
Decision Date November 20, 2009
Days to Decision 53 days
Submission Type Abbreviated
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code JJX — Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class I - General Controls
CFR Regulation 21 CFR 862.1660